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Glucocorticoid-regulated Glycoprotein Maturation 
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Gary  L. Firestone,* Nancy  J. John,*  and Keith R.  Yamamoto¢ 
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California 94720; tDepartment ofBiochemistry and Biophysics, University of California at San Francisco, San Francisco, 
California 94143 
Abstract. Glucocorticoid hormones can regulate the 
posttranslational maturation of mouse mammary tumor 
virus (MTV) precursor polyproteins in M1.54, a stably 
infected rat hepatoma cell line. We have used 
complement-mediated cytolysis to recover variants of 
M1.54 that fail to express MTV cell surface glycopro- 
teins in a hormone-regulated manner (Firestone, 
G. L., and K. R. Yamamoto, 1983, Mol. Cell. Biol., 
3:149-160). One such clonal isolate, CR4, is similar to 
wild-type with respect o synthesis of MTV mRNAs, 
production of the MTV glycoprotein precursor 
(gPr74 °nv) and a glycosylated maturation product 
(gp51), and hormone-induced processing of two MTV 
phosphoproteins. In contrast, three viral cell surface 
glycoproteins (gp78, gp70, and gp32) and one extracel- 
lular species (gp70s), which derive from gPr74 env in 
glucocorticoid-treated wild-type cells, fail to appear in 
CR4. CR4 showed no apparent alterations in prolifera- 
tion rate, cell shape, or expression of total functional 
mRNA and bulk glycoproteins. We conclude that the 
genetic lesion in CR4 defines a highly selective 
hormone-regulated glycoprotein maturation pathway 
that alters the fate of a restricted subset of precursor 
species. 
p OLYPEPTIDES destined to be membrane associated or secreted undergo a series of specific processing and 
compartmentalization reactions during and after 
translation (21, 44, 50, 52, 57, 62, 63). Cell biological and 
genetic data (1, 11, 17, 48, 51, 52, 59) suggest that shuttle vesi- 
cles selectively transport polypeptides from the rough en- 
doplasmic reticulum into the Golgi stacks, through the Golgi 
cisternae and to their final intra- or extracellular locations, 
apparently subjecting the polypeptides toan ordered array of 
modifications. For example, different Golgi cisternae appear 
to contain specific glycosyltransferases that modify glyco- 
protein substrates during passage through individual com- 
partments (7, 8, 10, 21, 44). In addition, fatty acid modifica- 
tion of certain polypeptide backbones appears to occur at 
specific loci within the Golgi region (7, 9, 55). Different pro- 
teins with similar final destinations appear to use separate 
transport pathways (15, 52, 58), and certain pathways eem 
to include branch points that specify alternative processing 
fates (3, 14, 19, 31). Given the complexity, generality, and 
overall importance of these vents, it would not be surprising 
if they were exploited for regulation of the relative levels of 
specific final products. Indeed, secretion of ACrH (19, 32) 
and parathormone (6) may be modulated by cAMP, although 
little is known of the mechanisms of these phenomena. 
Glucocorticoids appear to regulate the posttranslational 
maturation of mouse mammary tumor virus (MTV) 1 glyco- 
1. Abbreviations used in this paper: endo H, endo-I]-N-acetylglucosamini- 
dase H; MTV, mouse mammary tumor virus. 
proteins and phosphoproteins i  M1.54, an MTV-infected rat 
hepatoma cell line containing 10 stably integrated proviruses 
(13, 14). For example, the predominant viral glycoprotein 
produced by control cultures is an extracellular 51,000 Mr 
species (gpSls), whereas hormone-treated cells produce two 
extracellular forms (gp51s and gp70s), and three cell surface 
species (gp78, gpT0, and gp32). In addition, dexamethasone 
facilitates maturation of two new viral phosphoproteins (p24 
and p35), derived by proteolytic leavage from their com- 
mon phosphorylated polyprotein (14, 24). Finally, the hor- 
monal signal has a third effect on MTV gene expression, 
stimulating the rate of MTV RNA synthesis by increasing 
selectively the efficiency of MTV promoter utilization (5, 18, 
38--40, 43, 46, 53, 60, 61, 64). Thus, glucocorticoids govern 
the absolute levels as well as the maturation of MTV proteins 
in M1.54. The present study, together with previous evidence 
(13), suggests that the three glucocorticoid-regulated path- 
ways are genetically distinct. 
The normal cellular targets for the hormone-controlled 
posttranslational processes have not been identified; how- 
ever, the MTV polypeptides provide sensitive and perhaps 
general substrates for identifying and characterizing the 
regulated pathways. For example, we have selected and ana- 
lyzed M1.54 variants defective in the maturation of certain 
MTV glycoprotein species in the presence of hormone. One 
such mutant line, CR4, expresses MTV RNA normally but 
fails to produce mature cell surface viral glycoproteins (13). 
In this report, we define molecular features of hormone- 
regulated glycoprotein maturation by comparing the expres- 
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sion and processing of MTV glycoproteins in the parent and 
mutant cell lines. 
Materials and Methods 
Materials 
k-[35S]Methionine (1,000 Ci/mmol) and D-[2-3H]mannose (16 Ci/mmol) 
were obtained from Amersham Corp. (Arlington Heights, IL); [9,10- 
3H(N)]-palmitic acid was from New England Nuclear (Boston, MA); 
dexamethasone was from Sigma Chemical Co. (St. Louis, MO); and 
agarose derivatized with castor bean lectin (Ricin)-120 was from P-L Bio- 
chemical, Inc. (Milwaukee, WI). All antisera (4) were generous gifts of L. 
J. T. Young and R. D. Cardiff (Department of Pathology, University of 
California, Davis); endo-I~-N-acetylglucosaminidase H (endo H) was a gift 
of Regis Kelly (Department ofBiochemistry and Biophysics, University of 
California, San Francisco). All other reagents were of highest available 
purity. 
Cells and Method of Culture 
M1.54 is a cloned line of MTV-infected rat hepatoma tissue culture (HTC) 
cells (47); selection of its complement-resistant derivative CR4 has been de- 
scribed previously (13). Cells were cultured in DME supplemented with 5 % 
horse serum as described (14). Where indicated, dexamethasone was added 
to the culture medium to a final concentration f 1 IxM. Cell cultures were 
radiolabeled with [35S]methionine in methionine-deficient medium, with 
[2-3H]mannose in glucose/mannose-deficient medium, and with [9,10- 
3H]palmitic acid in normal medium, in each case supplemented with 1% 
dialyzed FCS. 
Pulse-Chase Experiments 
Monolayer cultures were preincubated with 1 I~M dexamethasone for 24 h 
and pulse-labeled for 20 min with 1(30 IxCi [3SS]methionine or 150 p.Ci [2- 
3Hlmannose; the cultures were rinsed several times with PBS and then in- 
cubated in medium supplemented with 1% horse serum and either unlabeled 
methionine (1mg/ml) or unlabeled mannose (1mg/ml). Where noted, dexa- 
methasone was present in the medium throughout both incubation periods. 
At the indicated times, the secreted fraction was harvested by centrifugation 
of the culture medium at 600 g for 3 rain; the resulting supernate was frozen 
immediately in liquid nitrogen and stored at -20°C. Cell monolayers were 
washed twice in ice-cold PBS, released from the plates in 10 mM Tris-HC1, 
pH 7.5, 1 mM EDTA, and centrifuged at600 g for 3 min; cell pellets were 
frozen immediately in liquid nitrogen and stored at -20°C. Acid hydrolysis 
and subsequent thin layer chromatography of [2-3Hlmannose-labeled gly-
coproteins revealed that the radiolabel remained within mannose. 
Steady-state Incorporation ofRadiolabeled Material 
Cultures were incubated 12 h at 37°C in appropriate media with either 50 
~tCi [35S]methionine, 100 ~tCi [2-3H]mannose, or 500 I~Ci [9,10-3H(N)]pal - 
mitic acid; cellular and extracellular fractions were harvested as described 
above. Hormone-treated cultures were preincubated with dexamethasone 
for 24 h as well as during the radiolabeling period. Approximately 10-fold 
more extracts were immunoprecipitated from any uninduced extracts to 
compensate for the independent glucocorticoid stimulation i  MTV RNA 
synthesis. Intact cells were iodinated at the cell surface as described previ- 
ously (12). 
Iramunoprecipitation of MTV Polypeptides 
Cells were homogenized at 107 per ml in solubilization buffer (1% Triton 
X-100, 0.5% deoxycholate, 5 mM EDq'A, 250 mM NaCI, 25 mM Tris-HC1, 
pH 7.5) and centrifuged 15 min at 20,000 g; the supernatant was used for 
immunoprecipitation. Secreted fractions were brought o 1% Triton X-100, 
0.5% deoxycholate, and 5 mM EDTA just before immunoprecipitation. To- 
tal radiolabeled proteins were analyzed by precipitating an aliquot (I0 ~tl) 
of the soluble fraction with 10% TCA. MTV proteins were immunoprecipi- 
tated from detergent-solubilized extracts using formaldehyde-fixed Staphy- 
lococcus aureus (26) by a low background assay described previously (42). 
SDS Gel Electrophoresis and Autoradiography 
Staphylococcus aureus pellets were solubilized in 25 ~tl SDS gel sample 
buffer (30) and 0.5 M dithiothreitol (DTT) at 100°C for 2 min; after a 2-rain 
Eppendorf centrifugation, the supernatants were electrophoresed in SDS 
polyacrylamide gels containing 9.5% acrylamide. Proteins were subse- 
quently fixed and stained overnight with 0.4% Coomassie Brilliant Blue in 
10% acetic acid, 25% isopropanol. Gels were destained in 10% acetic acid 
for 4 h, impregnated with EN3HANCE (New England Nuclear) for 1 h, 
rinsed in water for 1 h, dried at 80°C, and analyzed by fluorography on Ko- 
dak RP Royal Xomat film in the presence of a Dupont Cronex "Lightning 
Plus" intensifying screen at -70°C. 
Endo H Digestion 
Immunoprecipitated MTV proteins were digested with endo H by modifica- 
tion of the method of Zilberstein et al. (65). After eluting the radiolabeled 
antigens from S. aureus in 30 ~tl of SDS gel sample buffer, 30 I~1 of 0.3 M 
sodium citrate, pH 5.5, was added in the presence or absence of 0.5 mg/ml 
endo H and incubated for 16 h at 37°C. Radiolabeled proteins were precipi- 
tated with 700 ~tl of acidified acetone (acetone 5 N HCI, 40:1) at 4°C for 
10 min; precipitated proteins were harvested by centrifugation at 10,000 g 
for 10 min. SDS gel sample buffer and DTT were added to the pellets for 
electrophoresis. 
Cell Proliferation Assay 
M1.54 and CR4 cells were plated at an initial density of 104 cells per 2-cm 2 
well (Corning multi-well plate; Coming Glass Works, Coming, NY) and 
treated 24 h after plating with 1 la-M dexamethasone. At various times 
through 6-d time course, triplicate samples of cells were fixed in 70 % etha- 
nol, dried in vacuo at room temperature, and 0.4 ml of 10% 3,5-diamino- 
benzoic acid-dihydrochloride (Aldrich Chemical Co., Milwaukee, WI) was 
added to each well. After 1 h at 60°C, 2 ml of 1 N HCl was added and the 
DNA-mediated fluorescence (22) in each solution monitored at excitation 
and emission wavelengths of 405 and 465-540 nm, respectively, in a Model 
112 Turner fluorimeter. Under these conditions, a reading of one fluores- 
cence unit equals 104 cells. 
RNA Isolation and In Vitro Translation 
Total RNA was isolated from M1.54 and CR4 cells exposed to 1 )xM dexa- 
methasone, translated in vitro in a rabbit reticulocyte lysate (41), and 
[35S]methionine-labeled proteins were analyzed by two-dimensional gel 
electrophoresis (35) as described previously (13). 
Results 
Analysis of Mutant CR4 Proliferation, Cell Shape, and 
Functional mRNA 
Using complement-mediated cytolysis, the CR4 mutant line 
was isolated on the basis of its inefficient expression of cell 
surface MTV polypeptides in the presence of dexamethasone 
(13). Conceivably, gross differences in cell growth rate or 
shape could give rise to this phenotype. Glucocorticoids 
have been shown to affect cell proliferation, in particular 
producing a nearly complete inhibition of cell growth in cer- 
tain hepatoma lines (20). As shown in the graph in Fig. 1, 
M1.54 and CR4 each display doubling times of '~25 h in the 
absence of hormone and both show only a modest (18 %) de- 
crease in growth rate in the presence of dexamethasone. 
Similarly, light microscopic comparisons ofCR4 and M1.54 
cultures propagated 6 d in the presence or absence of hor- 
mone (Fig. 1; four images), revealed no systematic differ- 
ences in cell shape; independent of hormone treatment, each 
cell line was epithelial-like and somewhat flattened with 
polygomal structures. Thus, in contrast to a previous report 
(23), we concluded that cell shape per se does not appear to 
account for the defective localization of cell surface MTV 
polypeptides in CR4. 
To survey the expression of functional mRNA in M1.54 
and CR4, total cellular RNA was isolated from hormone- 
induced cells, translated in vitro in a rabbit reticulocyte ly- 
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Figure 1. Proliferation and shape of dexamethasone-treated n  untreated MI.54 and CR4 cells. (Left) MI.54 and CR4 cells were plated 
in the presence or absence of 1 laM dexamethasone and the DNA content was analyzed by a diaminobenzoic acid fluorescence assay through 
a 6-d time course. Using a standard curve, DNA-mediated fluorescence was monitored at the indicated times and converted to cell number 
per cmL (Right) At the 6-d time point, cells were examined by light microscopy. Bar, 50 lain. 
sate (41), and the translation products analyzed by two- 
dimensional gel electrophoresis (35). As shown in Fig. 2, 
M1.54 and CR4 RNAs yielded nearly identical patterns of in 
vitro translation products, suggesting that CR4 expresses 
normally the vast majority of its functional mRNA; consis- 
tent with this view, the overall rates of protein synthesis in 
hormone-induced and uninduced CR4 and M1.54 are indis- 
tinguishable as assessed by the incorporation of [3SS]methi- 
onine during 5-min pulse labeling (data not shown). Inter- 
estingly, comparison of the gels from Fig. 2 with those of 
translation products from untreated cultures revealed two 
major hormone-inducible species in both lines, a~-acid gly- 
coprotein (22,000 Mr) and a 50,000 Mr secreted glycopro- 
tein (43,000 Mr primary product). Thus, the lesion in CR4 
appears to affect he expression of a restricted subset of gene 
products while general competence for glucocorticoid re- 
sponsiveness i retained. 
Figure 2. Two-dimensional gel electrophoresis of in vitro transla- 
tion products from M1.54 and CR4 cells. The cell-free translation 
system was programmed with 10 I-tg of total RNA isolated from 
M1.54 (top) or CR4 (bottom) that had been propagated in the pres- 
ence of I taM dexamethasone. Samples (2 I-tl) were analyzed by two- 
dimensional electrophoresis with80% pH 5-8 and 20% pH 3.5- 
10 ampholines in the isoelectric focusing (IEF) dimension. The 
molecular mass tandards are B-galactosidase (120,000 Mr), BSA 
(68,000 Mr), ovalbumin (43,000 Mr), aldolase (40,000 Mr), and 
chymotrypsinogen (25,000 M3. The arrows denote the 42,000 Mr 
(50-kD secreted glycoprotein) a d 22,000 Mr (~t~-acid glycopro- 
tein) in vitro translation products induced by dexamethasone. 
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Figure 3. Pulse-chase analysis of intracellu- 
lar and secreted MTV glycoproteins pro- 
duced in dexamethasone-treated nd un- 
treated cultures of M1.54 and CR4 cells. 
(Right panels) Cultures of M1.54 and CR4 
were exposed to 1 IxM dexamethasone for
24 h, and then pulse-labeled with 100 IxCi 
[2-3H]mannose for 20 min followed by fur- 
ther incubation i  the presence of excess un- 
labeled mannose; dexamethasone was pres- 
ent throughout the experiment. The cellular 
(upper right) and extracellular (lower right) 
fractions were harvested immediately after 
the pulse (lanes E, I, M, P, e, f, m, and n) 
and after 30 (lanes F, J, N, Q, g, h, o, and 
p), 75 (lanes G, K, i, j, q, and r), and 120 
(lanes H, L, O, R, k, l, s, and t) min of 
subsequent chase; detergent-solubilized ex- 
tracts were immunoprecipitated with either 
anti-MTV (lanes E-L, e, g, i, k, rn, o, q, 
and s) or preimmune sera (lanes M-R, f, h, 
j, l, n, p, r, and t), fractionated by SDS 
PAGE, and analyzed by fluorography. (Left 
panels) Uninduced cultures of M1.54 and 
CR4 cells were pulse-labeled with 100 I~Ci 
[2-3H]mannose for 20 min followed by fur- 
ther incubation with excess unlabeled man- 
nose. Cellular (upper left) and extracellular 
(lower left) fractions were harvested, im- 
munoprecipitated with either anti-MTV 
(lanes A-D, b, and d) or preimmune sera 
(lanes a and c), fractionated in SDS poly- 
acrylamide gels, and the labeled proteins 
were visualized by fluorography. Approxi- 
mately 10-fold more extract protein was 
used for immunoprecipitations from control 
relative to hormone-treated cell extracts to 
compensate for quantitative differences in 
MTV RNA levels reflecting the indepen- 
dent effect of dexamethasone on MTV tran- 
scription. Lanes A, a, and b are pulse 
points; lane B, 30 min of chase; lane C, 75 
min of chase; and lanes D, c, and d, 120 
min of chase. 
Expression of MTV Glycoproteins in M1.54 and CR4 
To examine MTV glycoprotein maturation, M1.54 and CR4 
cultures exposed to 1 IJ, M dexamethasone for 24 h were 
pulse-labeled with [2-3H]mannose followed by additional 
incubation in the presence of excess unlabeled mannose. At 
various times, [2-3H]mannose-labeled viral glycoproteins 
were immunoprecipitated with anti-MTV antibodies, frac- 
tionated in SDS polyacrylamide gels, and visualized by 
ttuorography. As shown in Fig. 3 (lanes E-H), dexametha- 
sone-treated M1.54 initially synthesizes a 74,000 Mr precur- 
sor glycoprotein (designated gPr74 e"V) that is subsequently 
matured into four major species (pg78, gp70, gp51, and 
gp32); several other minor or transiently expressed viral gly- 
coproteins are also produced. Hormone-treated CR4 also 
produces gPr74 e°V (upper panel, lane I),  but its subsequent 
processing is dramatically different (lanes J-L); gp78, gp70, 
and gp32 expression is reduced or undetectable in CR4, 
whereas several other gPr74~"v-derived species, most nota- 
bly gp51, are produced competently. We have suggested pre- 
viously that specific portions of the MTV protein maturation 
pathways are dexamethasone inducible. To compare the 
hormone-regulated species in M1.54 with those deficient in 
CR4, uninduced cultures of M1.54 were pulse-labeled with 
[2-3H]mannose, followed by subsequent incubation with ex- 
cess mannose, immunoprecipitation f MTV glycoproteins, 
and fractionation by electrophoresis. As shown in Fig. 3 
(lanes A-D), untreated cells synthesize gPr74 e"v, but pro- 
duce little detectable [2-3H]mannose-labeled gp78, pg70, 
and gp32. Thus, the production of gPr74e°v-derived glyco- 
proteins in control M1.54 (lanes A-D) is strikingly similar 
to that in hormone-treated CR4 (lanes l-L), suggesting that 
the genetic lesion in CR4 specifically blocks the hormonal 
regulation of glycoprotein maturation. 
This notion was tested further by analyzing the extracellu- 
lar viral glycoproteins. We established previously that at 
steady state, hormone-treated M1.54 produce two free ex- 
tracellular MTV polypeptides (70,000 Mr and 51,000 Mr) in 
approximately equimolar amounts, while control cells se- 
crete predominantly (>95%) the 51,000 Mr species (14). 
Fig. 3 shows glycoproteins pulse-labeled with [2-3H]man - 
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Figure 4. Cell surface-associated and 
intracellular MTV glycoproteins. Hor- 
mone-treated (24 h) M1.54 cells were ei- 
ther radiolabeled at the cell surface by 
lactoperoxidase-mediated [~25I]iodina- 
tion (lanes A-E) or metabolically la- 
beled for 24 h with 100 p.Ci [2-3H]man - 
nose (lanes F-J). Cell extracts were 
immunoprecipitated with anti-MTV an- 
tibodies (lanes A and F), monospeci- 
fic anti-gp51 antibodies (lanes B and 
G), monospecific anti-gp32 antibodies 
(lanes C and H), monospecific anti-p28 
antibodies (lanes D and H), or preim- 
mune serum (lanes E and J). Immuno- 
precipitated polypeptides were fraction- 
ated by SDS PAGE and visualized by 
autoradiography or fluorography. 
nose that are secreted after a 120-min chase; dexamethasone- 
treated cells secrete qual levels of [2-3H]mannose-labeled 
70,000 Mr and 51,000 Mr species (lanes e-l) while control 
cultures ecrete predominantly the 51,000 Mr product (lanes 
a-d); these extracellular viral glycoproteins, designated 
gp70s and gp51s, account for at least 60% of the total syn- 
thesized MTV glycoproteins at steady state. Importantly, 
hormone-treated CR4 secretes a drastically reduced level of 
gp70s relative to that released from M1.54 (lanes m-t). Thus, 
CR4 appears to carry a defect in a hormone-induced glyco- 
protein maturation pathway that controls the appearance of
particular cellular and secreted viral glycoproteins. 
Identification of Cell Surface MTV Glycoproteins 
The expression in CR4 of a specific subset of gPr74 .... 
derived maturation products uggests that the CR4 mutation 
may uncouple two distinct pathways for MTV glycoprotein 
maturation, one of which yields cellular gp78, gp70, and gp32 
in the presence of hormone. To examine the relationships of
these hormone-regulated glycoproteins and to determine 
those species located at the cell surface, plasma membrane 
proteins accessible on intact cells were labeled by lacto- 
peroxidase-catalyzed [~25I]iodination (Fig. 4, lanes A-E), 
while a parallel culture was metabolically abeled with [2- 
3H]mannose (Fig. 4, lanes F-J). Immunoprecipitation with 
anti-MTV antibodies (lanes A and F) revealed that he iodin- 
ated 78,000 Mr, 70,000 Mr, 51,000 Mr, and 32,000 Mr cell 
surface species co-migrate inSDS gels with the predominant 
viral glycoproteins gp78, pg70, gp51, and gp32, respectively, 
whereas everal of the minor MTV glycoproteins are not de- 
tected at the cell surface. Monospecific anti-gp51 antibodies 
recognized both iodinated and [2-3H]mannose-labeled forms 
of the 78,000 Mr, 70,000 Mr, and 51,000 Mr species (Fig. 4, 
lanes B and G) while monospecific anti-gp32 antibodies 
recognize a cell surface 32,000 Mf glycoprotein (Fig. 4, 
lanes C and H) in addition to the two stable polyproteins 
(78,000 Mr and 70,000 Mr species). A minor [125I]-labeled 
species migrating at 20,000 Mr was also detected by anti- 
gp32 antibodies and may represent a specific proteolytic 
fragment of gp32. In contrast, none of the iodinated cell sur- 
face or [2-3H]mannose-labeled viral polypeptides were de- 
tected with preimmune or antiphosphoprotein sera. 
These results demonstrate that the cell surface MTV poly- 
peptides are glycosylated, and that gp32 and gp51 are im- 
munologically distinct, while gp78 and gp70 appear to be 
polyproteins containing all or portions of the polypeptide 
backbones for both gp51 and gp32. In fact, sequence analysis 
of the GR virus env gene revealed that gp51 is the amino- 
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terminal portion of the polyprotein while gp32 is the 
carboxy-terminal domain and contains the transmembrane 
hydrophobic region (45). Interestingly, gp51 is associated 
with the cell surface despite its lack of a membrane anchor; 
conceivably gp51 may be associated with another primary 
integral membrane protein during transport to the cell sur- 
face. Consistent with this mechanism, we have shown that 
after multiple freeze-thaw at -100°C of isolated micro- 
somes, which elutes luminal components of vesicles, gp51 
remains associated with the membrane fraction (Haffar, 
O .K., C. P. Edwards, and G. L. Firestone, manuscript sub- 
mitted for publication). Finally, the cell surface viral glyco- 
proteins that fail to appear in CR4 (gp78, gp70, and gp32) 
have in common the polypeptide backbone for gp32 suggest- 
ing a crucial maturation or sorting domain may be contained 
within its structure. Thus, defective posttranslational matu- 
ration of the MTV glycosylated precursor appears to account 
for the absence of gp78, gp70, and gp32 from the CR4 cell 
surface. Since M1.54 and its derivatives contain 10 nontan- 
demly integrated MTV proviruses (13), all of which seem 
transcriptionally active (Harris, C., and K. R. Yamamoto, 
unpublished data), the CR4 defect is likely to reflect a lesion 
in a cellular gene, rather than a mutation in the env gene itself 
or elsewhere within MTV sequences. 
Endo H Sensitivity of MTV Glycoproteins 
In general, glycoprotein modification and maturation in- 
clude addition of "high mannose" moieties in the rough en- 
doplasmic reticulum which are further processed uring 
transit hrough the Golgi stacks into "complex" oligosaccha- 
ride sidechains (21, 27, 28). Endo H, which specifically 
hydrolyzes the high-mannose species, was used to exam- 
ine oligosaccharide maturation of [35S]methionine-labeled 
MTV glycoproteins from dexamethasone-treated cells. As 
shown in Fig. 5, both externalized species, gp51s and gp70s 
(whose expression in CR4 is reduced several fold), appear 
to contain a heterogeneous mixture of endo H-resistant and 
-sensitive carbohydrate side chains. Moreover, the pattern of
endo H sensitivity is indistinguishable in M1.54 and CR4, 
implying that the altered maturation of particular MTV gly- 
coproteins in CR4 is not due simply to a global defect in 
oligosaccharide processing. 
Endo H treatment of [3SS]methionine-labeled MTV gly- 
coproteins immunoprecipitated from both M1.54 and CR4 
yielded a 62,000 Mr gPr74 e"v derivative; a parallel experi- 
ment with [2-3H]mannose-labeled glycoproteins revealed 
that all of the [2-3H]mannose in gPr74 env is removed (data 
not shown). In contrast, the [2-3H]mannose radiolabel in 
the membrane-associated gp78, gp70, gp51, and gp32 prod- 
ucts remained attached, as expected for complex oligosac- 
charide side chains (data not shown). Finally, the glycosyl- 
ated MTV precursors produced in M1.54 and CR4 migrate 
indistinguishably in two-dimensional gels (data not shown), 
suggesting that they are identical. 
Attachment of pH]Palmitate to MTV Glycoproteins 
For certain plasma membrane proteins, covalently attached 
fatty acid residues appear to "anchor" the protein within the 
membrane (55); in the case of the vesicular stomatitis virus 
G protein, this lipid modification likely occurs during trans- 
port through the cis Golgi region soon after the acquisition 
Figure 5. Endo H sensitivity of extracellular viral glycoproteins. 
M1.54 (lanes C and D) and CR4 (lanes A and B) cells were in- 
cubated for 24 h with I p.M dexamethasone i  the presence of 150 
laCi [35S]methionine. Equal amounts of viral glycoproteins were 
immunoprecipitated from extracellular fractions and subjected to 
endo H digestion as described in the text. MTV polypeptides were 
subsequently fractionated in SDS polyacrylamide g ls and visual- 
ized by fluorography. Molecular mass standards were as desc ibed 
in Fig. 2. In a parallel experiment, endo H digestion of gPr74 c°V 
resulted in a 62,000 Mr species missing only its "high-mannose" 
oligosaccharides. 
of endo H resistance (7). When M1.54 and CR4 cultures 
were incubated for 24 h with [3H]palmitate in the presence 
or absence of dexamethasone, only the hormone-inducible 
gp78, gp70, and gp32 species became labeled (Fig. 6, right 
panel, lane C); in particular, no palmitate-labeled viral pro- 
teins were detected in either control (lane E) or hormone- 
treated (lane G) CR4. Labeling of parallel cultures with 
[35S]methionine (Fig. 6, left panel), showed that CR4 failed 
to express the polypeptide backbones for gp78, gp70, and 
gp32, rather than producing aberrant species unable to ac- 
quire the lipid modification. 
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Figure 6. Analysis of [3H]pal- 
mitic acid-labeled and [35S]me- 
thionine-labeled viral proteins. 
(Left) M1.54 (lanes A and B) and 
CR4 cells (lanes C and D) were 
exposed to 1 pM dexametha- 
sone for 24 h and radiolabeled 
with 25 BCi [35S]methionine 
during the last 4 h of hormone 
treatment. Proteins immuno- 
precipitated with anti-MTV an- 
tibodies (lanes A and C) or 
preimmune serum (lanes B and 
D) were fractionated in SDS 
polyacrylamide g ls and visu- 
alized by fluorography. Pr74 
denotes the position of two dis- 
tinct MTV polyprotein precur- 
sors encoding the glycosylated 
and phosphorylated viral pro- 
teins; p35 and p24 are mature 
MTV phosphoproteins (see ref- 
erences 14 and 22). (Right) 
M1.54 (lanes A-D) and CR4 
(lanes E-H) cells were labeled 
with 0.5 mCi [3H]palmitic acid 
for 24 h in the presence (lanes 
C, D, G, and H) or absence 
(lanes A, B, E, and F) of 1 pM 
dexamethasone, and extracts 
were immunoprecipitated either 
with anti-MTV antibodies 
(lanes A, C, E, and G) or with 
preimmune serum (lanes B, D, 
F, and H); radiolabeled MTV 
proteins were fractionated by 
SDS gel electrophoresis and 
analyzed by fluorography. Mo- 
lecular weight standards for 
both panels were as in Fig. 2. 
These results revealed that palmitate modification is a bio- 
chemical feature common to the cell surface MTV glycopro- 
teins not expressed in CR4 cells. It is clear, however, that 
palmitate modification itself is neither hormone-dependent 
in M1.54 nor defective in CR4, since the specific activity of 
[3H]palmitate incorporated into TCA-precipitable material 
from dexamethasone-treated and untreated M1.54 and CR4 
are similar (Table I). Table I also shows that [3H]fucose and 
[2-3H]mannose incorporation levels in the two lines are 
equivalent; moreover, hormone-treated and control M1.54 
and CR4 produce similar [3H]palmitate-modified and [2- 
3H]mannose-labeled cellular glycoproteins (Haffar, O. K., 
and G. L. Firestone, unpublished ata), establishing further 
that bulk glycoprotein expression in CR4 is unaffected. 
Discussion 
A variety of sorting mechanisms operate upon glycoproteins 
to effect heir maturation and transit o membrane-associated 
or extracellular locations (17, 21). For example, in active or 
carrier-mediated pathways, vesicle or organelle-associated 
"sorting receptors" have been postulated to bind and segre- 
Table I. Incorporation of Lipid and Sugar Precursors by Wild-type and Mutant Cell Lines 
Cell line Dexamethasone [3H]Palmitate [2-3]Mannose [3HlFucose 
cpm/mg* cpm/mg~; cpm/mg§ 
M 1.54 - 461,000 138,000 71,000 
M1.54 + 395,000 135,000 68,000 
CR4 - 421,000 129,000 75,000 
CR4 + 454,000 145,000 76,000 
* Cells were incubated with or without 1 ~tM dexamethasone for 24 h in the presence of1 mCi [3H]palmitate, d tergent solubilized, an  the level of radioactive 
lipid incorporated into protein was determined by precipitation with 10% TCA. Specific incorporation is expressed ascpm/mg of precipitated protein. 
The incubation a d assay conditions were the same as described n previous footnote, xcept that the cells were incubated with 200 p.Ci of [2-3H]mannose. 
§ The incubation and assay conditions were the same as described n the first footnote, except that he cells were incubated witb 200 ~tCi of I3H]fucose. 
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gate selectively the appropriate glycoprotein substrates (2, 
25), presumably by recognizing features of the polypeptide 
backbone or of the oligosaccharide side chains, as with the 
mannose-6-phosphate receptors involved in targeting lyso- 
somal hydrolases (10, 56). Previous work of others uggests 
that some of these processes may be amenable to genetic dis- 
section in cultured cells (57, 59). For example, Kabat and co- 
workers have isolated mutants defective in processing Friend 
murine leukemia virus or Friend spleen focus-forming virus 
envelope glycoproteins (16, 49), and Zilberstein et al. (65) 
have recovered variants that fail to produce cell surface- 
associated and lipid-modified vesicular stomatitis virus gene 
products. The novel feature of our results is the identification 
of a defect in a hormone-regulated posttranslational process. 
We conclude that the MTV glycoprotein precursor can be 
partitioned differentially into either a glucocorticoid-induci- 
ble or a constitutive trafficking pathway in cultured rat hepa- 
toma cells. This finding demonstrates that global physiologi- 
cal regulators uch as steroid hormones can effect acute 
changes in the products expressed from specific genes even 
after their transcription. 
The ability of hormone-treated CR4 and control cultures 
of M1.54 to survive in the presence of MTV-specific anti- 
serum and complement reflects the absence of high levels 
of cell surface-associated gp78, gp70, and gp32; only in 
hormone-treated M1.54 does gPr74 env proceed efficiently 
through the maturation and sorting pathway that results in the 
membrane localization of these species. Thus, dexametha- 
sone appears either to mediate an increase in a particular 
subset of transport or targeting activities or to stimulate the 
entry of gPr74 env into a pre-existing sorting route. It may be 
relevant in this regard that the cell surface glycoproteins ot 
expressed inCR4 contain the polypeptide backbone for gp32 
(the COOH-terminal domain of gPr74~nv), perhaps indicat- 
ing that a sorting signal resides within that structure. 
In any case, the genetic lesion in CR4 displays ahighly re- 
stricted phenotype, blocking selectively the hormonal induc- 
tion of a glycoprotein maturation pathway that operates upon 
a specific subset of target precursors. Notably, the glucocor- 
ticoid receptor appears normal in CR4, and we have demon- 
strated that several hormone-responsive genes are regulated 
competently (13). Moreover, the gPr74 env species produced 
in hormone-treated and control M1.54 and CR4 are indistin- 
guishable with respect o molecular weight, migration in 
two-dimensional gels, glycosidase sensitivity, and lectin 
affinity. In addition, bulk glycoprotein processing and com- 
partmentalization appear normal in CR4, in contrast, for ex- 
ample, to the global alterations in intracellular p otein traffic 
seen in the yeast secretory mutants defined by Scheckman 
and coworkers (33, 34, 54). Similarly, control and hormone- 
treated M1.54 and CR4 are indistinguishable in the produc- 
tion of total palmitate-derivatized polypeptides (data not 
shown). Since the membrane-destined MTV glycoproteins 
normally produced in hormone-treated M1.54 and absent in 
CR4 are all palmitate modified, it seems likely that the 
hormone-regulated branch point resides at or before palmi- 
tate addition. 
The regulatory mechanism by which the glucocorticoid 
receptor alters glycoprotein processing and compartmental- 
ization is unknown. The putative hormone-regulated factors 
identified by the CR4 mutation might function directly in the 
processing of specific glycoproteins, ormay operate as intra- 
cellular sorting receptors (25), analogous to the actions of 
egasyn and 132-microglobulin, which are essential for mem- 
brane association of 13-glucuronidase (37) and HLA antigens 
(29, 36), respectively. Alternatively, the regulated factors 
might facilitate membrane vesicle flow into particular intra- 
cellular compartments, or maintain localization of specific 
target proteins ubsequent tovesicle fusion (10, 25). In any 
case, inhibitors of RNA synthesis prevent he hormone- 
regulated glycoprotein maturation events (Haffar, O. K., and 
G. L. Firestone, manuscript submitted for publication). 
Thus, one simple interpretation is that glucocorticoids may 
regulate the transcription fgenes encoding certain receptors 
or processing enzymes, and that the expression of one or 
more of these genes is defective in CR4. 
Using MTV glycoproteins a targets for genetic selection 
and as intracellular biochemical probes, we have been able 
to detect and characterize a regulated posttranslational gly- 
coprotein expression pathway without indications a priori of 
its existence, its normal cellular target proteins, or its biolog- 
ical significance. Conceivably, a pathway of this type could 
efficiently redirect the maturation and targeting fates of even 
large existing pools of glycoproteins simply by altering the 
synthesis or degradation fa single factor. This could facili- 
tate subtle or dramatic transitions in specific glycoprotein lo- 
calization, such as might be involved, for example, in cell 
membrane r modeling during development and differentia- 
tion. Of course, the precise nature of the regulated events and 
the regulatory signals themselves are likely to be cell 
specific. Thus, cAMP appears to control the externalization 
of mature ACTH in pituitary cells (19, 32). Through further 
characterization of CR4 and other genetic variants, it should 
be possible to identify cellular proteins whose maturation 
and targeting are controlled by glucocorticoids and to eluci- 
date the normal biological function of this phenomenon. 
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